Kiichi Murakami

1.7k total citations
19 papers, 1.2k citations indexed

About

Kiichi Murakami is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Kiichi Murakami has authored 19 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 8 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Kiichi Murakami's work include Immunotherapy and Immune Responses (6 papers), Immune Response and Inflammation (5 papers) and NF-κB Signaling Pathways (5 papers). Kiichi Murakami is often cited by papers focused on Immunotherapy and Immune Responses (6 papers), Immune Response and Inflammation (5 papers) and NF-κB Signaling Pathways (5 papers). Kiichi Murakami collaborates with scholars based in Canada, United States and Japan. Kiichi Murakami's co-authors include Pamela S. Ohashi, Razqallah Hakem, Elzbieta Matysiak‐Zablocki, Alisha R. Elford, Bénédicte Lemmers, Leonardo Salmena, Anne Hakem, Andrew Wakeham, Laura Tamblyn and Amro Shehabeldin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Kiichi Murakami

19 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kiichi Murakami Canada 13 695 638 276 153 125 19 1.2k
Jagan Muppidi United States 16 760 1.1× 647 1.0× 221 0.8× 171 1.1× 115 0.9× 33 1.3k
Katherine Oravecz-Wilson United States 23 696 1.0× 418 0.7× 273 1.0× 167 1.1× 118 0.9× 50 1.3k
Rika Ouchida Japan 20 585 0.8× 411 0.6× 187 0.7× 180 1.2× 106 0.8× 31 1.1k
Konstantin V. Salojin Canada 18 571 0.8× 683 1.1× 225 0.8× 156 1.0× 89 0.7× 21 1.3k
Alicia Algeciras-Schimnich United States 15 836 1.2× 564 0.9× 195 0.7× 223 1.5× 178 1.4× 21 1.3k
Diego G. Silva Australia 15 485 0.7× 677 1.1× 132 0.5× 158 1.0× 101 0.8× 22 1.3k
H. Elizabeth Broome United States 12 516 0.7× 385 0.6× 192 0.7× 110 0.7× 54 0.4× 29 1.1k
Nigel Sharfe Canada 19 570 0.8× 959 1.5× 278 1.0× 137 0.9× 114 0.9× 33 1.7k
Loredana Fiorentino Italy 14 672 1.0× 352 0.6× 209 0.8× 232 1.5× 250 2.0× 17 1.2k
Muriel D. David France 20 851 1.2× 397 0.6× 283 1.0× 197 1.3× 44 0.4× 26 1.5k

Countries citing papers authored by Kiichi Murakami

Since Specialization
Citations

This map shows the geographic impact of Kiichi Murakami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kiichi Murakami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kiichi Murakami more than expected).

Fields of papers citing papers by Kiichi Murakami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kiichi Murakami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kiichi Murakami. The network helps show where Kiichi Murakami may publish in the future.

Co-authorship network of co-authors of Kiichi Murakami

This figure shows the co-authorship network connecting the top 25 collaborators of Kiichi Murakami. A scholar is included among the top collaborators of Kiichi Murakami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kiichi Murakami. Kiichi Murakami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Murakami, Kiichi, et al.. (2024). Inhibition of Notch enhances efficacy of immune checkpoint blockade in triple-negative breast cancer. Science Advances. 10(44). eado8275–eado8275. 3 indexed citations
2.
Murakami, Kiichi, Valentin Sotov, Marcus O. Butler, et al.. (2024). Caspase-1-dependent spatiality in triple-negative breast cancer and response to immunotherapy. Nature Communications. 15(1). 8514–8514. 3 indexed citations
3.
Murakami, Kiichi, Andrew Elia, Yukiko Shibahara, et al.. (2021). Therapeutic inhibition of USP9x-mediated Notch signaling in triple-negative breast cancer. Proceedings of the National Academy of Sciences. 118(38). 49 indexed citations
4.
Martin, Kea, Kiichi Murakami, Laura Israël, et al.. (2019). Malt1 Protease Deficiency in Mice Disrupts Immune Homeostasis at Environmental Barriers and Drives Systemic T Cell–Mediated Autoimmunity. The Journal of Immunology. 203(11). 2791–2806. 14 indexed citations
5.
Shen, Qiang, Brenda Cohen, Ramtin Rahbar, et al.. (2017). Notch Shapes the Innate Immunophenotype in Breast Cancer. Cancer Discovery. 7(11). 1320–1335. 92 indexed citations
6.
Dissanayake, Dilan, et al.. (2014). Peptide-Pulsed Dendritic Cells Have Superior Ability to Induce Immune-Mediated Tissue Destruction Compared to Peptide with Adjuvant. PLoS ONE. 9(3). e92380–e92380. 14 indexed citations
7.
Johnson, Dylan, Lily Pao, Salim Dhanji, et al.. (2013). Shp1 regulates T cell homeostasis by limiting IL-4 signals. The Journal of Experimental Medicine. 210(7). 1419–1431. 79 indexed citations
8.
Johnson, Dylan, et al.. (2013). Shp1 regulates T cell homeostasis by antagonizing IL-4 signalling (P1312). The Journal of Immunology. 190(Supplement_1). 119.14–119.14. 1 indexed citations
9.
Murakami, Kiichi, et al.. (2011). Effect of An Hour-Long Stereoscopic Film on Human Body. i-Perception. 2(8). 869–869. 1 indexed citations
10.
Dissanayake, Dilan, Håkan Hall, Alisha R. Elford, et al.. (2011). Nuclear factor-κB1 controls the functional maturation of dendritic cells and prevents the activation of autoreactive T cells. Nature Medicine. 17(12). 1663–1667. 62 indexed citations
11.
Su, Yu‐Wen, Zhenyue Hao, Atsushi Hirao, et al.. (2011). 14-3-3σ regulates B-cell homeostasis through stabilization of FOXO1. Proceedings of the National Academy of Sciences. 108(4). 1555–1560. 34 indexed citations
12.
Murakami, Kiichi, Nicole Liadis, Alisha R. Elford, et al.. (2010). Caspase 3 is not essential for the induction of anergy or multiple pathways of CD8+ T‐cell death. European Journal of Immunology. 40(12). 3372–3377. 4 indexed citations
13.
Murakami, Kiichi, Nien‐Jung Chen, Samuel D. Saibil, et al.. (2009). DNA damage- and stress-induced apoptosis occurs independently of PIDD. APOPTOSIS. 14(9). 1039–1049. 42 indexed citations
14.
Deenick, Elissa K., Laurence Chapatte, Kiichi Murakami, et al.. (2009). c‐Rel phenocopies PKCθ but not Bcl‐10 in regulating CD8+ T‐cell activation versus tolerance. European Journal of Immunology. 40(3). 867–877. 9 indexed citations
15.
Lemmers, Bénédicte, Leonardo Salmena, Nicolas Bidère, et al.. (2007). Essential Role for Caspase-8 in Toll-like Receptors and NFκB Signaling. Journal of Biological Chemistry. 282(10). 7416–7423. 147 indexed citations
16.
Liadis, Nicole, Kiichi Murakami, Mohamed Eweida, et al.. (2005). Caspase-3-Dependent β-Cell Apoptosis in the Initiation of Autoimmune Diabetes Mellitus. Molecular and Cellular Biology. 25(9). 3620–3629. 123 indexed citations
17.
Salmena, Leonardo, Bénédicte Lemmers, Anne Hakem, et al.. (2003). Essential role for caspase 8 in T-cell homeostasis and T-cell-mediated immunity. Genes & Development. 17(7). 883–895. 396 indexed citations
18.
Nguyen, Linh T., Alisha R. Elford, Kiichi Murakami, et al.. (2002). Tumor Growth Enhances Cross-Presentation Leading to Limited T Cell Activation without Tolerance. The Journal of Experimental Medicine. 195(4). 423–435. 105 indexed citations
19.
Murakami, Kiichi, Shintaro Sato, Shigeharu Nagasawa, & Toshiyuki Yamashita. (2000). Regulation of mast cell signaling through high-affinity IgE receptor by CD45 protein tyrosine phosphatase. International Immunology. 12(2). 169–176. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jagan Muppidi Breakdown of academic impact, for papers by Katherine Oravecz-Wilson Breakdown of academic impact, for papers by Rika Ouchida Breakdown of academic impact, for papers by Konstantin V. Salojin Breakdown of academic impact, for papers by Alicia Algeciras-Schimnich Breakdown of academic impact, for papers by Diego G. Silva Breakdown of academic impact, for papers by H. Elizabeth Broome Breakdown of academic impact, for papers by Nigel Sharfe Breakdown of academic impact, for papers by Loredana Fiorentino Breakdown of academic impact, for papers by Muriel D. David
Rankless by CCL
2026